Hf. Sewell et al., CHEMOTHERAPY-INDUCED DIFFERENTIAL CHANGES IN LYMPHOCYTE SUBSETS AND NATURAL-KILLER-CELL FUNCTION IN PATIENTS WITH ADVANCED BREAST-CANCER, International journal of cancer, 55(5), 1993, pp. 735-738
To elaborate a rational approach to chemoimmunotherapy in humans, info
rmation is required as to how current cytotoxic chemotherapy regimens
modulate patients' endogenous immune cells. We have studied a group of
16 advanced breast cancer patients who received cyclical cytotoxic ch
emotherapy (CMF-cyclophosphamide, methotrexate and 5-fluorouracil) and
have documented the progressive differential effects of chemotherapy
on endogenous immune cells as judged by changes in immunophenotype and
absolute numbers of lymphocyte subsets, together with analysis of nat
ural-killer-cell function. Cells with the immunophenotype of natural k
iller cells and lymphokine-activated killer cells (NK/LAK cells) were
well retained, but their function was suboptimal. Additionally, CD8 T
cells were well preserved, but the numbers of CD4 T cells decreased wi
th succeeding cycles of chemotherapy; B-cell numbers decreased rapidly
from the first cycle of chemotherapy. These cellular changes in human
s indicate defined and precisely timed windows of opportunity for intr
oducing in vivo, simple and direct immune stimulation of the cells mod
ulated by chemotherapy, with the possibility of improving therapy and
survival in this disease. (C) 1993 Wiley-Liss, Inc.